Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00670618
Other study ID # 2008/187 - Part 2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2008
Est. completion date April 26, 2011

Study information

Verified date May 2023
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Influence of CPP-ACP paste and Elmex Medical Gel on the prevention of white spot lesions in orthodontic patients during fixed appliances.


Recruitment information / eligibility

Status Completed
Enrollment 325
Est. completion date April 26, 2011
Est. primary completion date January 21, 2011
Accepts healthy volunteers No
Gender All
Age group 10 Years to 60 Years
Eligibility Inclusion Criteria: - No white spot lesion at the time of placement of fixed appliances Exclusion Criteria: - White spots already present before start orthodontic treatment

Study Design


Related Conditions & MeSH terms


Intervention

Device:
CPP-ACP (GC Tooth Mousse)
Calcium and phosphate
CPP-ACP (GC MI Paste Plus)
Calcium, phosphate and fluoride
Fluoride (Elmex Medical Gel)
Fluoride

Locations

Country Name City State
Belgium University Hospital Ghent Ghent

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Ghent GC Europe

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevention of the opacity of white spots during orthodontic treatment with fixed appliances After 2 years
See also
  Status Clinical Trial Phase
Completed NCT00670670 - A Prospective, Randomized Clinical Study on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 1 N/A